By proceeding, you agree to our Terms of Use and Privacy Policy.
Founded in 2009, Global Health Press provides specific information, resources as well as advice on infectious diseases and vaccinology to our readers to help them better understand their subject, diagnosed conditions, and the current approaches related to vaccination, prevention, screening, and diagnosis.
27-27 April 2023
This article discusses the potential of utilizing mRNA technology, which has been popularized during the COVID-19 pandemic, to create safe and effective vaccines for the influenza virus. Traditional influenza vaccines offer varying levels of immunity
Event Ended
Virtual
Paid